Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demircan

Showing results (911-920 of 970) with videos related to

Pageof 97
Sort By:
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 1, 2022
Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremitiesTugba Akin Telli, Ozkan Alan, Nazim Can Demircan, et al.
Nature Medicine|April 30, 2026
Data-driven prioritization of high-risk individuals for weight loss interventionsKamil Demircan, Julia Carrasco-Zanini, Alice Williamson, et al.
Redox Biology|July 9, 2023
Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormoneQian Sun, Elisa Oltra, D A Janneke Dijck-Brouwer, et al.
Anatolian Journal of Cardiology|June 8, 2023
A Novel Composed Index to Evaluate the Right Ventricle Free-Wall Adaptation Against Ventricular Wall Stress in Acute Pulmonary EmbolismAykun Hakgör, Hacer Ceren Tokgöz Demircan, Berhan Keskin, et al.
Journal of Clinical Medicine|March 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCRAyberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 10, 2026
Trace element dynamics following low-calorie formula diet and their association with glycaemic traitsSophie Leonore Jahn, Kamil Demircan, Thilo Samson Chillon, et al.
World Journal of Surgical Oncology|September 10, 2020
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?Ozkan Alan, Tugba Akin Telli, Bilge Aktas, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2019
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanibNazım C Demircan, Özkan Alan, Tuğba Başoğlu Tüylü, et al.
BMC Cancer|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH scoreBurak Pacaci, Buket Erkan Ozmarasali, Adem Deligonul, et al.
Journal of Clinical Medicine|January 28, 2026
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and SafetySerhat Çelik, Zeynep Tuğba Karabulut, Cem Selim, et al.
Pageof 97

Showing results (911-920 of 970) with videos related to

Sort By:
Pageof 97
Orthopaedics & Traumatology, Surgery & Research : OTSR|December 1, 2022
Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremitiesTugba Akin Telli, Ozkan Alan, Nazim Can Demircan, et al.
Nature Medicine|April 30, 2026
Data-driven prioritization of high-risk individuals for weight loss interventionsKamil Demircan, Julia Carrasco-Zanini, Alice Williamson, et al.
Redox Biology|July 9, 2023
Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormoneQian Sun, Elisa Oltra, D A Janneke Dijck-Brouwer, et al.
Anatolian Journal of Cardiology|June 8, 2023
A Novel Composed Index to Evaluate the Right Ventricle Free-Wall Adaptation Against Ventricular Wall Stress in Acute Pulmonary EmbolismAykun Hakgör, Hacer Ceren Tokgöz Demircan, Berhan Keskin, et al.
Journal of Clinical Medicine|March 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCRAyberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 10, 2026
Trace element dynamics following low-calorie formula diet and their association with glycaemic traitsSophie Leonore Jahn, Kamil Demircan, Thilo Samson Chillon, et al.
World Journal of Surgical Oncology|September 10, 2020
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?Ozkan Alan, Tugba Akin Telli, Bilge Aktas, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2019
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanibNazım C Demircan, Özkan Alan, Tuğba Başoğlu Tüylü, et al.
BMC Cancer|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH scoreBurak Pacaci, Buket Erkan Ozmarasali, Adem Deligonul, et al.
Journal of Clinical Medicine|January 28, 2026
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and SafetySerhat Çelik, Zeynep Tuğba Karabulut, Cem Selim, et al.
Pageof 97